Insider · SEC Form 4 · Former 10% Owner
Cormorant Asset Management, LP
In the 12 months to Nov 19, 2026, on the open market: sold $1.7M of CRBP. Filed 2 business days after the trade.
Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these
- CRBPSold: Corbus Pharmaceuticals Holdings, Inc. $1.7M
Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.
Stakes filed (13D/13G)
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Filings made under this filer's SEC CIK in the same 12 months, newest first; the figure is the percentage the filing states. Every recent 13D and 13G
- CRBPCormorant Asset Management, LP 7.76%
- IBIOCormorant Asset Management, LP 9.99%
- QNCXCormorant Asset Management, LP 9.99%
- DRUGCormorant Asset Management, LP 9.17%
- EYPTCormorant Asset Management, LP 8.35%
- ANLCormorant Asset Management, LP 6.77%
- CABACormorant Asset Management, LP 5.95%
- RAPPCormorant Asset Management, LP 5.56%
- BIOACormorant Asset Management, LP 5.38%
- MLTXCormorant Asset Management, LP 4.35%
- RLYBCormorant Asset Management, LP 0%
- BLSMCormorant Asset Management, LP 3.13%